Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Filings indexed 396 across all filing types
Latest filing 2023-10-04 Regulatory Filings
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a formal regulatory announcement regarding the setting of a record date for shareholder list closure to determine eligibility for an Extraordinary General Meeting (EGM). This type of filing is a standard regulatory disclosure in the Korean market (KRX) and does not fit into specific categories like financial reports or proxy statements, thus it falls under the general regulatory filing category.
2023-10-04 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a corporate merger (회사합병 결정) between HLB Life Science and its subsidiary Hwajin Medical. It details the merger process, schedule, and financial implications. This type of filing is a standard regulatory disclosure for M&A activity in the Korean market, which falls under the 'M&A Activity' category.
2023-09-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (under the Financial Investment Services and Capital Markets Act) used to disclose significant changes in share ownership. This corresponds to the 'Major Shareholding Notification' category in the provided schema.
2023-09-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by insiders and major shareholders to report changes in their shareholdings. This corresponds to the 'Director's Dealing' (DIRS) category, which covers insider trades and changes in ownership by company directors and major shareholders.
2023-09-22 Korean
주요사항보고서(회사분할결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a corporate split (회사분할 결정), specifically a physical split (물적분할) of HLB Life Science. It details the split method, purpose, financial impact, and the creation of a new entity (HLB Solution). This type of regulatory filing in the Korean market, which details corporate restructuring, is classified under 'Regulatory Filings' (RNS) as it serves as a formal announcement of a significant corporate event that does not fit into specific categories like M&A (which usually implies a takeover or merger) or Share Issue (which is for capital changes).
2023-09-18 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for HLB Life Science, detailing the date, location, and agenda items (specifically a corporate split). This type of document, which provides information to shareholders regarding an upcoming meeting and requests their participation or voting, is classified as a Proxy Solicitation & Information Statement (PSI).
2023-09-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.